Romaco Holding GmbH Hired Michael Van den Bossche as the New...
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Romaco Holding GmbH Hired Michael Van den Bossche as the New Managing Director

By Pharma Tech Outlook | Monday, August 10, 2020

Jörg Pieper, CEO

Romaco Holding GmbH has announced that they will hire Michael Van den Bossche as the new Managing Director of Romaco Innojet, and it will be affected by 1 August 2020.

FREMONT, CA: Recently, Romaco Holding GmbH has announced that they will hire Michael Van den Bossche as the new Managing Director of Romaco Innojet, and it will be affected by 1 August 2020. In the new role, he will have the responsibility of Sales, Laboratory, Customer Service, and Product Management. Van den Bossche will also contribute to the management of Romaco Innojet with Bastian Käding, who has been at the wheel of the company since 2018 with the charge for Project Management, Engineering, Operations, and Administration.

Before entering Romaco Innojet, Belgian-born Van den Bossche, have a master’s degree in biochemical engineering. He even worked for different prominent international companies in the business of managing technologies, process design, and development. During his professional career, which is nearly two decades, he has earned extensive experience in the sale of processing solutions for the pharmaceutical and food industries. In the last few years, he was immensely concentrated on continuous technologies for manufacturing pharmaceutical solids. Since 2017, Van den Bossche has lived in Germany.

“We’re delighted to welcome Michael Van den Bossche on board as new joint Managing Director of Romaco Innojet,” explained Jörg Pieper, CEO Romaco Group. “His expertise when it comes to strengthening global sales structures and his strategic approach to the development of new business segments are impressive. We’re in no doubt that Mr. Van den Bossche will make a lasting contribution to the success of the Romaco Innojet brand.”

“I’ve always been very sales-minded, and service comes top of my list of priorities,” Michael Van den Bossche emphasized. “I’m also extremely familiar with the industry and I know exactly what our customers are looking for – in us and in our technologies. The expectations people place in suppliers are particularly high in the pharmaceutical industry with its strict regulations. There’s a high demand for enduring technologies and cost-effective solutions that give customers a competitive advantage.”

Weekly Brief

Read Also